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Molecular mechanisms underlying the cold-associ-
ated high cardiovascular risk remain unknown.
Here, we show that the cold-triggered food-intake-
independent lipolysis significantly increased plasma
levels of small low-density lipoprotein (LDL) rem-
nants, leading to accelerated development of athero-
sclerotic lesions in mice. In two genetic mouse
knockout models (apolipoprotein E/ [ApoE/]
and LDL receptor/ [Ldlr/] mice), persistent cold
exposure stimulated atherosclerotic plaque growth
by increasing lipid deposition. Furthermore, marked
increase of inflammatory cells and plaque-associ-
ated microvessels were detected in the cold-accli-
mated ApoE/ and Ldlr/ mice, leading to plaque
instability. Deletion of uncoupling protein 1 (UCP1),
a key mitochondrial protein involved in thermogene-
sis in brown adipose tissue (BAT), in the ApoE/
strain completely protected mice from the cold-
induced atherosclerotic lesions. Cold acclimation
markedly reduced plasma levels of adiponectin,
and systemic delivery of adiponectin protected
ApoE/mice from plaque development. These find-
ings provide mechanistic insights on low-tempera-
ture-associated cardiovascular risks.
INTRODUCTION
Atherosclerosis-associated cardiovascular disease (CVD) re-
mains the leading cause of mortality in the Western society
and most other parts of the world (Libby et al., 2011; Maseri
et al., 2011). Recent studies show that colder ambient tempera-
ture is associated with an increased incidence of myocardial
infarction (MI) and other atherosclerosis-related vascular disor-
ders such as stroke (Bhaskaran et al., 2009; Palmer, 2010).118 Cell Metabolism 18, 118–129, July 2, 2013 ª2013 Elsevier Inc.Abundant evidence from epidemiological studies has linked car-
diovascular disorders to the cold seasons or low ambient tem-
perature (The Eurowinter Group, 1997; Barnett, 2007; Basu
et al., 2005; Braga et al., 2001; Morabito et al., 2005; Wolf
et al., 2009). Despite this long-known linkage between cold
and high CVD risk, mechanisms underlying cold-induced CVD
remain poorly understood, although snow removal during the
winter season has been claimed to be associated with increased
CVD incidence (Franklin et al., 2001; Janardhanan et al., 2010).
In rodents, cold exposure can sufficiently activate brown adi-
pose tissue (BAT), leading to increased levels of nonshivering
thermogenesis via activation of the sympathetic system (Lowell
and Spiegelman, 2000; Nedergaard et al., 2001; Rosen and
Spiegelman, 2006; Shabalina et al., 2006; Xue et al., 2009). Addi-
tionally, low ambient temperature can sufficiently stimulate
phenotypic and functional conversion from white adipose tissue
(WAT) into brown-like adipose tissue (BRITE) in an uncoupling
protein 1 (UCP1)-dependent manner (Nedergaard et al., 2001;
Petrovic et al., 2010; Xue et al., 2009). Interestingly, the cold-
induced transition from WAT into BRITE is also associated with
an increased density of blood vessels that provide oxygen as a
fuel to cope with the high rate of metabolism (Cao, 2010; Xue
et al., 2009). A substantial amount of BAT exists in adult humans,
and cold augments BAT activation (Celi, 2009; Cypess et al.,
2009; Enerba¨ck, 2009; Timmons and Pedersen, 2009; van
Marken Lichtenbelt et al., 2009; Virtanen et al., 2009), which
may have a paradoxical impact on health. In a healthy adult,
BAT activation may lead to a lean and healthier phenotype.
Conversely, cold-triggered high metabolic rates may alter
plasma lipid profiles, leading to accelerated development and
progression of metabolically related disorders, such as athero-
sclerosis and diabetes, if an individual already suffers from this
type of disorder. The latter possibility has not been investigated.
Atherosclerotic plaques typically occur in the aortic, coronary,
carotid, and cerebral arteries (Libby et al., 2011) and thus are
closely associated with high incidences of CVD and stroke
(Eaton, 2005). Deletion of apolipoprotein E (ApoE) and low-
density lipoprotein receptor (Ldlr) in mice leads to development
of atherosclerotic lesions in the aorta and its branches, due to
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Powell-Braxton et al., 1998).
In this study, we investigated the impact of cold-induced BAT
activation-associated lipolysis on atherosclerotic plaque forma-
tion and stability in both ApoE/ and Ldlr/ mice. We report
our findings that cold exposure significantly accelerated the
atherosclerotic plaque growth and instability in both genetic
models by the mechanism of accelerated UCP1-dependent
lipolysis. Cold-associated reduction of plasma adiponectin
levels is significantly involved in the accelerated development
of atherosclerotic plaques. Our work sheds light on the mecha-
nisms that underlie cold-induced cardiovascular risks that may
pave an avenue for the treatment and prevention of atheroscle-
rosis-associated CVD.
RESULTS
Cold Exposure Activates BAT and Induces BRITE
To study the effect of low temperature on alterations of bothWAT
and BAT in ApoE/ mice, 8-week-old adult animals that were
fed with a high-fat diet (HFD) for 4 weeks were divided into 2
groups (n = 20/group). One group of mice was transferred to
30C, the thermoneutral temperature; under this condition, the
metabolic rate remained at the basal level. The other group of
mice was adapted to 18C for 1 week prior to exposure to 4C.
Mice in both groups were pair-fed with regular chow for sub-
sequent studies. At the end of week 8 after cold exposure, total
weights of subcutaneous WAT (sWAT) and epididymal WAT
(eWAT) were significantly reduced (Figure 1A). Histological anal-
ysis of sWAT showed that the average size of the adipocytes was
markedly smaller in the cold-exposed group as compared with
those exposed to the thermoneutral temperature (Figures 1A
and 1B). Due to a smaller adipocyte size, the number of adipo-
cytes per field was relatively increased (Figure 1A).
Cellular contents of 4C sWAT were markedly increased and
contained a high density of hematoxylin and eosin (H&E)-stained
structures (Figure 1B). Immunohistochemical analysis demon-
strated that high expression levels of UCP1, a specificmitochon-
drial protein for BAT, were present in 4C sWAT, whereas UCP1
levels were completely undetectable in 30C sWAT (Figures 1B
and 1C). Kinetic studies demonstrated that these alterations in
WATs were readily detected after 4-week exposure to cold (Fig-
ure S1 available online). These findings demonstrate that expo-
sure of ApoE/mice to cold led to conversion of WAT in various
depots into BRITE. Cold exposure also augmented the activation
of interscapular BAT (iBAT) by increasing UCP1 expression (Fig-
ures 1B and 1C). In addition to alterations of adipocytes, the
microvessel density in 4CWATs and 4C iBAT was significantly
increased (Figures 1B and 1C), validating the fact that cold expo-
sure could switch to an angiogenic phenotype in the adipose
tissue (Xue et al., 2009).
Activation of Lipolysis andMetabolismbyCold Exposure
Nonshivering thermogenesis-related metabolism can be de-
tected by measuring the metabolic rate in response to norepi-
nephrine (NE) (Xue et al., 2009). As expected, exposure of
ApoE/ mice to cold for 8 or 4 weeks led to marked elevation
of the metabolic rate as measured by O2 consumption and
CO2 production (Figures 1D andS1D). These findings are consis-tent with the decrease of body weight and body mass index
(BMI) due to a high metabolic rate during cold acclimation (Fig-
ure S1C). The cold-triggered high metabolic rate and lipolysis
are likely to alter blood lipid profiles. Indeed, the level of plasma
triglyceride (TG) was significantly decreased (Figure 1H), further
validating the cold-induced body weight loss. Conversely, levels
of cholesterol, LDL cholesterol, and glycerol were increased by
2- to 3-fold, whereas the level of free fatty acid (FFA) remained
unchanged (Figure 1H). Fast protein liquid chromatography
(FPLC) analysis of plasma cholesterol under cold exposure
showed that the proportion of very low-density lipoprotein
(VLDL) was particularly increased (Figure 1I). Similarly, interme-
diate-density lipoprotein (IDL) and the proportion of LDL were
also markedly increased by cold exposure. Conversely, plasma
levels of the high-density lipoprotein (HDL) cholesterol compo-
nent remained virtually unchanged (Figure 1I). We next studied
cholesterol synthesis by intraperitoneal injection with [3H]water.
Intriguingly, the hepatic cholesterol synthesis rate was markedly
increased in cold-exposed ApoE/mice (Figure 1J). Consistent
with the increased level of cholesterol synthesis, hydroxymethyl-
glutaryl-coenzyme A reductase (HMG-CoA reductase) and tran-
scriptional factors essential for cholesterol synthesis, including
sterol regulatory element-binding proteins (SREBPs) transcrip-
tion factor and its partner protein SREBP cleavage-activating
protein (SCAP), were also markedly increased (Figure 1J).
Inversely, plasma levels of TG were markedly decreased in
cold-exposed ApoE/ mice relative to those of the thermo-
neutral temperature-exposed group (Figure 1H). Similar results
were also obtained from mice exposed to cold for 4 weeks
(Figure S1H).
To exclude the effect of HFD in cold-induced hyperlipidemia,
we performed experiments in which mice were fed with regular
diet throughout the entire experiment. As expected, similar
cold-induced hypercholesterolemia, plaque growth, and insta-
bility were also seen in these regular chow-fed ApoE/ mice
(Figures S3B–S3D). These results show that cold-triggered
metabolic changes in the adipose tissue alter the blood lipid pro-
files by accumulating atherosclerosis-prone lipids. Since the
sympathetic system is involved in activation of BAT- and
BRITE-associated lipolysis (Xue et al., 2009), which subse-
quently regulates hepatic cholesterol synthesis, we treated
ApoE/ mice with a known b3-adrenergic receptor-selective
blocker, SR-59230A. Interestingly, SR-59230A significantly in-
hibited the cold-induced hypercholesterolemia, plaque develop-
ment, and instability (see below for description of measures of
stability; Figures S3F–S3H).
We also analyzed blood lipid profiles in cold-exposed healthy
mice. Similar to ApoE/ mice, prolonged exposure to cold
significantly decreased body weight and BMI in genetically non-
manipulated healthymice (Figure S4A). Plasma levels of TGwere
significantly decreased (Figure S4B). However, plasma levels of
total cholesterol, LDL cholesterol, and HDL cholesterol were all
significantly decreased (Figure S4B). These findings opposed
the high cholesterol levels seen in ApoE/ mice. One possible
explanation of these discrepant findings between healthy and
ApoE/ mice could be the high rate of cholesterol clearance
in healthy mice. In support of this notion, hepatic Ldlr and
ApoE levels were markedly increased in cold-exposed healthy
mice (Figure S4C). In addition to the pair-fed protocol, ad libitumCell Metabolism 18, 118–129, July 2, 2013 ª2013 Elsevier Inc. 119
Figure 1. Cold-Induced WAT-BRITE Conversion, BAT Activation, Blood Lipid Profile, Lipolysis, and Cholesterol Synthesis of ApoE–/– Mice
(A) Tissue weights of sWAT, eWAT, and iBAT depots from ApoE/ mice exposed to 4C or 30C for 8 weeks (n = 20/group). Average diameters and average
numbers of adipocytes of sWAT, eWAT, and iBAT exposed to 4C or 30C for 8 weeks (10 random fields/group 3 5 mice).
(B) Tissue sections of sWAT and iBAT exposed to 4C or 30C for 8 weeks were stained with H&E, mitochondrial UCP1, endomucin, and CD31.
(legend continued on next page)
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cholesterol and LDL cholesterols in response to cold exposure
(Figure S4E). Consistent with cold-induced hypercholesterole-
mia, accelerated plaque growth and instability were also
observed in these ad libitum fed mice (Figures S4F and S4G).
We have also measured the plasma levels of corticosterone.
There was no statistical difference between the 4C and 30C
groups after 4 weeks of exposure. However, a statistical differ-
ence has been observed after prolonged exposure (8 weeks),
suggesting that mice experienced chronic stress (Figure S1G).
Elevated Expression Levels of Lipolysis-Associated
Gene Products
To study alteration of expression levels of metabolically associ-
ated genes, a genome-wide microarray analysis was performed
in four groups (4C for 1 week, 4C for 5 weeks, 30C for 1 week,
and 30C for 5 weeks) using the inguinal WAT (iWAT), which
exhibited an obvious BRITE phenotype. Gene cluster and princi-
ple component analyses demonstrated that gene expression
patterns were highly reproducible. As expected, a number of
lipolysis-related genes, including fabp3, ucp1, elovl3, cpt1b,
thea, cox7a1, gyk, pank1, pdk4, cox8b, idh3a, gys2, gpd2,
acdav1, ndufab, acaa2, and pparg1b, were highly expressed in
4C for 1 week or 4C for 5 week iWAT (Figures 1E and S1B).
Noticeably, many of these cold, highly-induced lipolysis-associ-
ated genes are crucial enzymes for oxidative and lipid degrada-
tion. Consistent with gene profile alterations, high expression
levels of several key lipolysis genes were further validated by
quantitative real-time PCR (qPCR) analysis (Figures 1F and
S1E). To further define the molecular players that are involved
in lipolysis in the adipose tissue, expression levels of cyclic
AMP (cAMP), an essential signaling component of lipolysis in
the adipose tissue, were analyzed in 4C eWAT and 30C
eWAT. Interestingly, the cAMP level in the 4C eWAT group
was significantly increased relative to the 30C eWAT group (Fig-
ures 1F and S1F). Furthermore, adipocytes from 4C eWAT and
30C eWAT were isolated and incubated in the presence or
absence of isoproterenol (ISO). As expected, stimulation of
ISO-treated 4C eWAT adipocytes significantly increased the
release of glycerol, indicating that the high rate of lipolysis
occurred in these cells.
Cold Exposure Stimulates Atherosclerotic Plaque
Growth in ApoE–/– Mice
Knowing that cold acclimation increased plasma levels of VLDL
and small LDL remnants in ApoE/ mice, we next investigated
the consequence of alteration of lipid profiles in affecting
atherosclerotic plaque growth. Surprisingly, gross examination(C) Quantification of UCP1+ signals, endomucin+microvessel density per adipocy
30C for 8 weeks (10 random fields/group 3 5 mice).
(D) Metabolic rate of O2 consumption and CO2 production in response to NE (n
(E) Expression profiles of lipolysis-related genes in iWAT exposed to 4C or 30C
(F) Measurement of cAMP and glycerol levels in eWAT exposed to 4C or 30C f
(G) qPCR analysis of expression levels of lipolysis-related genes in iWAT expose
(H) Blood chemistry analysis of TG, cholesterol, LDL cholesterol (LDL-C), FFA, a
(I) FPLC analysis of plasma cholesterol and TG in groups exposed to 4C or 30
(J) In vivo analysis of the hepatic cholesterol synthesis rate in groups exposed to
cholesterol synthesis-related genes from liver tissues of groups exposed to 4C
norepinephrine.by general oil red O staining revealed that arteries, including
the aorta arch, thoracic artery, abdominal artery, and common
iliac artery, contained widespread atherosclerotic plaques
throughout the artery stem after 4- and 8-week exposure to
cold (Figure 2A). The average size of plaque areas was sub-
stantially increased after prolonged 8-week exposure to cold,
though the plaques in the 30C control group showed a
tendency to grow at a slow rate (Figures 2A and 2B). The exis-
tence of large atherosclerotic plaques in the 4C groups was
further validated by oil red O staining (Figure 2B). Prolonged
exposure of ApoE/ mice to cold for 8 weeks led to markedly
accelerated atherosclerotic plaque growth, whereas the
average plaque size in the 30C group remained unchanged
(Figures 2A and 2B). These findings demonstrate that cold
significantly augments atherosclerotic plaque growth in main
arteries of ApoE/ mice.
Cold Acclimation Augments Atherosclerotic Plaque
Instability in ApoE–/– Mice
Immunohistochemical analysis showed that a-smooth muscle
actin (a-SMA) positive structures and Sirius red+ collagen I struc-
tures in atherosclerotic plaques were significantly decreased
after 4- and 8-week-long cold acclimation, while oil red O+ lipid
area and MOMA-2+ area were significantly increased. (Fig-
ure 2B). In light of these changes, the plaque instability indexes
in 4 week and 8week 4Cgroups were increased in several mag-
nitudes relative to the 30C control groups (Figure 2B). The pla-
que instability index was calculated according to the following
formula: (oil red O+ area plus MOMA-2+ area) / (a-SMA+ area
plus collagen I+ area). Atherosclerotic plaques in the group
exposed to 4C contained large necrotic core areas, which
were progressively enlarged during prolonged exposure to
cold (Figures 2C and 2D). Further, the thickness of the fibrous
cap in plaques exposed to 4C was significantly decreased
relative to those of the group exposed to 30C (Figure 2D).
Both increases of necrotic areas and decreases of the fibrous
cap thickness indicate that cold exposure increases plaque
instability and potential plaque disruption. Notably, other plaque
instability factors, including microvessels, inflammatory cells,
and inflammatory cytokines, were all markedly increased in pla-
ques exposed to 4C (Figures S2D–S2G).
Cold Acclimation Induces Atherosclerotic Plaque
Growth and Instability in Ldlr–/– Mice
To study if the cold-augmented atherosclerotic plaque growth
and instability generally occurred in other mouse models and
was not only restricted to ApoE/ mice, we used the Ldlr/
mouse strain (Powell-Braxton et al., 1998) to validate ourte, and CD31+microvessel density of sWAT, eWAT and iBAT exposed to 4C or
= 7/group).
for 5 weeks (3 repeats/group).
or 8 weeks (n = 5/group).
d to 4C or 30C for 8 weeks (n = 6/group).
nd glycerol (n = 12/group).
C for 8 weeks (n = 6/group).
4C or 30C for 8 weeks (n = 6/group). qPCR analysis of expression levels of
or 30C for 8 weeks (n = 6/group). AT, adipose tissue; AC, adipocyte; NE,
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Figure 2. Cold-Induced Atherosclerotic Plaque Growth and Instability in ApoE–/– Mice and Ldlr–/– Mice
(A) Gross examination and quantification of the general oil red O-stained aorta stem from ApoE/ mice exposed to 4C and 30C. (n = 10/group).
(B) Cross-section histological analysis and quantification of aorta roots exposed to 4C and 30C for 8 weeks by staining with H&E, oil red O, MOMA-2, a-SMA, or
Sirius red. Nonimmune IgGwas used as negative control. Dashed lines encircle some parts of atherosclerotic plaques, and arrowheads in different panels point to
positive signals (n = 10/group).
(C) Dashed lines encircle the necrotic core area. nec, necrotic core.
(legend continued on next page)
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produced in the Ldlr/ mouse strain, including cold-induced
WAT-to-BRITE transition, activation of BAT, adipocyte size
changes and UCP1 upregulation, lipolysis, body weight and
BMI decreases, cholesterol synthesis alterations of blood lipid
profiles, plaque growth, and instability index (Figures 2E–2H
and S2A–S2C). Taken together, these findings demonstrate
that cold acclimation induces atherosclerotic plaque growth
and instability in Ldlr/mice; thus, our findings may be reason-
ably generalized to other mouse strains.
Deletion of UCP1 Impairs Cold-Induced Lipolysis
Since cold-induced nonshivering thermogenesis requires acti-
vation of UCP1 (Nedergaard et al., 2001), we generated double
knockout mice that lacked ApoE and UCP1 (ApoE//UCP1/).
Immunohistological analysis confirmed that UCP1 expression in
4CWAT and BAT was completely ablated in ApoE//UCP1/
mice (Figure 3A). Cold-induced, nonshivering thermogenesis-
related metabolism, body weight and BMI losses, and lipolysis
were completely blocked in ApoE//UCP1/ mice (Figures
3B–3D), which also suffered from shivering behavior. After
4 week of exposure to 4C, blood cholesterol in ApoE//
UCP1/ mice was significantly decreased relative to that in
ApoE/ mice, and a greater than 5-fold decrease of LDL
cholesterol was detected (Figure 3E). Notably, deletion of the
Ucp1 gene also significantly reduced the basal level of LDL
cholesterol in ApoE//UCP1/ mice exposed to 30C for
4 weeks, indicating that UCP1 mediates BAT and muscle
metabolisms under the thermoneutral condition (Figure 3E).
Consistently, deletion of UCP1 led to a slight, but significant,
increase of blood TG in 4 week 4C ApoE//UCP1/ mice,
demonstrating the impaired basal level of lipolysis (Figure 3E).
These findings provide compelling evidence that deletion of
UCP1 completely abolishes the cold-induced lipolysis in the
adipose tissue.
The Role of UCP1 in Atherosclerotic Growth
Cold-induced atherosclerotic plaque growth was inhibited in
ApoE//UCP1/ mice relative to ApoE/ mice (Figure 3F).
The total amount of collagen I components was markedly
increased in atherosclerotic plaques of 4C ApoE//UCP1/
mice relative to 30C ApoE//UCP1/ mice. In a sharp
contrast to ApoE/ mice, deletion of UCP1 in 4 week 4C
ApoE//UCP1/mice led to an approximately 4-fold increase
of atherosclerotic plaque stability as compared with ApoE/
mice exposed to 4C for 4 weeks (Figure 3F). The plaque
fibrous cap thickness in 4 week 4C ApoE//UCP1/ mice
was considerably increased relative to 4 week 4C ApoE//
UCP1+/+ mice (Figure 3F). Deletion of the Ucp1 gene in
ApoE/ mice resulted in a marked decrease of cold-induced(D) Quantification of average necrotic core areas, the ratio of the necrotic core ar
exposed to 4C and 30C (n = 10/group).
(E) Metabolic rate of O2 consumption and CO2 production in response to NE in L
(F) Blood chemistry analysis of TG, cholesterol, and LDL levels (n = 8/group). FPLC
and 30C (n = 5/group).
(G) Measurement of cAMP and glycerol release in eWAT of Ldlr/ mice expose
(H) Quantification of plaque area and histological analysis of atherosclerotic plaqu
thoracic artery; Abd.A, abdominal artery; C.I.A, common iliac artery.necrotic core area compared with that in 4C ApoE//
UCP1+/+ mice.
Inhibition of Lipolysis and Cholesterol Synthesis
Attenuates Plaque Growth
To further validate our findings and strengthen our conclusions,
we studied the impact of lipolysis and cholesterol synthesis on
blood LDL levels and atherosclerotic plaque development. As
expected, inhibition of lipolysis by a known inhibitor, acipimox
(Guo et al., 2009), and inhibition of cholesterol synthesis by sim-
vastatin (Meng et al., 2012) significantly attenuated cold-induced
hyperlipidemia, atherosclerotic plaque growth, and instability
(Figures 3G, 3H, and S3A). Consistent with this finding, blood
levels of LDL cholesterol, but not HDL cholesterol, were signifi-
cantly reduced by both drugs. Interestingly, treatment of cold-
exposed ApoE/ mice with acipimox and simvastatin resulted
in a similar antiatherosclerotic effect, suggesting that lipolysis
and cholesterol synthesis are cohesively coupling processes
that contribute to cold-induced atherosclerosis. These findings
further validate our general conclusion that cold-induced lipol-
ysis is the causative mechanism of atherosclerotic plaque
development.
Essential Role of Adiponectin inMediatingCold-Induced
Atherosclerosis
To further elucidate molecular mechanisms that underlie cold-
induced atherosclerotic plaque growth and instability, we
analyzed adipokine levels in the plasma. Among the analyzed
adipokines, plasma adiponectin levels were consistently
decreased after 4 and 8 weeks of cold exposure in ApoE/
mice (Figure 4A). A similar level of plasma adiponectin reduction
was also found in non-HFD-fed ApoE/mice. A decreased level
of adiponectin suggests that this adipokine might participate in
regulation of lipid metabolism. We therefore investigated the
role of adiponectin in modulation of lipolysis. Surprisingly, sys-
temic delivery of adiponectin to cold-exposed ApoE/ mice
substantially decreased levels of the total cholesterol and LDL
cholesterol in the plasma (Figure 4B). Consistent with reduction
of hypercholesterolemia, systemic administration of adiponectin
inhibited plaque development to levels similar to that of plaques
exposed to 30C (Figure 4C). Similarly, adiponectin virtually
completely ablated the effect of the cold-induced plaque
instability (Figure 4C).
Since UCP1 is essentially required for cold-induced athero-
sclerotic plaque development in ApoE/ mice, we investigated
the relation between adiponectin and UCP1 expression. Inter-
estingly, systemic delivery of adiponectin almost completely
inhibited UCP1 messenger RNA (mRNA) expression in iBAT, as
detected by qPCR (Figure 4D). Consistent with decreases in
mRNA levels, UCP1 protein levels in iBAT were also markedlyea versus the aortic root plaque area, and the fibrous cap thickness in groups
dlr/ mice (n = 6–7/group).
analysis of plasma cholesterol and TG in pair-fed Ldlr/mice exposed to 4C
d to 4C and 30C for 8 weeks (n = 4–5/group).
es of aortic root in Ldlr/mice exposed to 4C and 30C (n = 10/group). Tho.A,
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ure 4E). In addition to BAT, UCP1 levels in cold-exposed sWAT
and eWAT were also significantly downregulated by adiponectin
(Figure 4E). We validated these findings using immunohisto-
chemical staining, showing that UCP1-positive signals were
sharply decreased in adiponectin-treated cold-exposed iBAT,
sWAT, and eWAT (Figure 4F). These findings demonstrate that
cold-induced suppression of adiponectin is, at least in large
part, responsible for cold-induced atherosclerotic plaque devel-
opment and instability in the ApoE/ mouse model.
Clinical Relevance
To translate our findings to clinical relevance, we conducted a
pilot experiment by recruiting human subjects to our studies.
We should emphasize that it was notoriously difficult to conduct
the cold-exposure experiment in human subjects, and themajor-
ity of requested individuals were unwilling to collaborate on this
project. We therefore could perform a pilot experiment by
recruiting a small number of individuals. Initially, we recruited
14 individuals; their information and disease history are shown
in Table S1. Individuals who had a history of smoking, drinking,
disease, or medication experiences within the last 2 months
were excluded. After blood lipid analysis, we finally recruited
five individuals who had high levels of plasma LDL. After 2-day
(2 hr/day) exposure to 16C with standard seminude cloth,
plasma levels of LDL cholesterol were measured. Consistent
with mouse models, plasma levels of LDL cholesterol were
significantly increased as compared with the levels prior to
cold exposure (Figure 4G). Importantly, plasma levels of adipo-
nectin were also significantly reduced, as seen in mouse models
(Figure 4G). This pilot human study further validates the clinical
relevance of our mouse studies. We admit the fact that only a
small number of human subjects were recruited at this time,
and this pilot study may lack a sufficient statistical power to
justify a definite conclusion.
DISCUSSION
In two genetic atherosclerotic mouse models, we provide
compelling evidence that cold acclimation activates lipolysis,
leading to high levels of blood cholesterol and LDL cholesterol,
especially VLDL and small LDL remnants, which are the coreFigure 3. Plasma Cholesterol Level and Atherosclerotic Plaque in
Alterations of BAT Activation, BMI, Metabolism, Blood Lipid Profile, At
(A) Histology and lack of UCP1 expression in eWAT and iBAT exposed to 4C an
(B) Metabolic rate of O2 consumption and CO2 production in response to NE (n
points.
(C) Body weight and BMI of pair-fed ApoE//UCP1/ mice exposed to 4C a
groups.
(D) Measurement of cAMP and glycerol levels released from eWAT of ApoE//UC
significance between the two groups.
(E) Blood chemistry analysis of cholesterol, LDL cholesterol, and TG levels of Ap
(F) Histological analysis of aorta roots of ApoE//UCP1/mice exposed to 4C a
red. H&E staining of the aorta roots of ApoE/ mice exposed to 4C and 30
atherosclerotic plaques, and arrowheads in different panels point to positive signa
areas, and fibrous cap thickness in ApoE//UCP1/ and ApoE/ mice (n = 6–
(G) FPLC analysis of plasma cholesterol in vehicle-, simvastatin- and acipimox-t
(H) Quantification of plaque areas and instability index of vehicle-, statin-, and ac
AUDK, ApoE//UCP1/.lipids of atherosclerotic plaques. There are two possible mecha-
nisms that potentially underlie the cold-induced hypercholester-
olemia: elevated synthesis or defective clearance. Since the
same phenotype was also observed in the Ldlr/, the cold-
induced hypercholesterolemia suggests that elevated synthesis
might be the underlying mechanism. Indeed, we show that levels
of VLDL and small LDL, but not HDL, were markedly increased
during cold exposure. Consistent with this notion, LDL synthetic
enzymes and transcription factors were also markedly upregu-
lated. However, the causal link between cold-induced BAT or
BRITE activation and increased cholesterol synthesis warrants
further mechanistic investigation. One of the intriguing findings
is that high plasma levels of VLDL and small LDL remnants
are only present in ApoE/ and Ldlr/ mice, but not in cold-
exposed healthy mice. While molecular mechanisms underlying
cold-induced differential effects in these genetically manipulated
and healthy mice warrant further investigation, this difference
may simply reflect the fact that fully functional clearance in
healthy mice would be able to reduce hypercholesterolemia to
a physiological level despite the high rate of cholesterol synthe-
sis. In ApoE/ and Ldlr/ mice, the existence of a defective
clearance function of plasma lipoproteins and cholesterols
may result in further accumulation of VLDL and small LDL rem-
nants when they are synthesized at high levels. Another possibil-
ity is that during cold exposure lipoproteins in ApoE/ and
Ldlr/ mice undergo substantial remodeling and would no
longer be cleared appropriately, leading to plasma accumulation
of small LDL remnants.
To link cold-induced lipolysis to atherosclerotic plaque
growth, we generated ApoE//UCP1/ mice in which Apoe
andUcp1 genes were completely deleted. As expected, deletion
of UCP1 virtually completely protected animals from cold-
induced atherosclerotic plaque growth. Although the detailed
molecular link between UCP1 expression and hypercholester-
olemia is not known at this time, activation of the sympathetic
nervous system is essentially required for the cold-induced
hypercholesterolemia and atherosclerotic plaque development.
We showed that blocking b3-adrenergic receptor using a
specific inhibitor virtually completely prevented cold-induced
hypercholesterolemia and accelerated plaque development,
demonstrating that cold-induced sympathetic activation is
crucial for this pathological process. Thus, the sympatheticSimvastatin- and Acipimox-Treated ApoE–/– Mice; Cold-Induced
herosclerotic Plaque Growth, and Stability in ApoE–/–/UCP1–/– Mice
d 30C for 4 weeks.
= 5–6/group). No statistical significance between the two groups at any time
nd 30C (n = 6–7/group), showing no statistical significance between the two
P1/mice exposed to 4C and 30C for 4 weeks (n = 4/group). No statistical
oE//UCP1/ or ApoE/ mice exposed to 4C and 30C (n = 6/group).
nd 30C for 4 weeks by staining with H&E, oil red O,MOMA-2, a-SMA, or Sirius
C for 4 weeks was used as a control. Dashed lines encircle some parts of
ls (n = 6–7/group). Quantification of plaque area, instability index, necrotic core
7/group).
reated apoE/ mice (n = 5/group).
ipimox-treated groups (n = 10/group). VT, vehicle-treated; NE, norepinephrine;
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Figure 4. Adiponectin Treatment and Clinical Relevance
(A) Plasma adiponectin levels of ApoE/ mice exposed to 4C and 30C (n = 10/group) that were fed HFD or regular diet for 4 and 8 weeks.
(B) Plasma cholesterol and LDL cholesterol levels of adiponectin- or vehicle-treated ApoE/ mice exposed to 4C or 30C (n = 10/group).
(C) Aorta root histological analysis of adiponectin- or vehicle-treated ApoE/mice exposed to 4C or 30C (n = 10/group) stained with H&E, oil red O, MOMA-2,
a-SMA, or Sirius red. Quantification of plaque areas, instability index, necrotic core areas, and fibrous cap thickness of adiponectin- or vehicle-treated ApoE/
mice exposed to 4C or 30C (n = 10/group).
(D) RelativemRNA expression levels of UCP1 in sWAT, eWAT, and iBAT from adiponectin- or vehicle-treated ApoE/mice exposed to 4Cor 30C (n = 5/group).
(E) Western blot analysis of UCP1 protein expression levels of sWAT, eWAT, and iBAT from adiponectin- or vehicle-treated ApoE/mice exposed to 4Cor 30C
(n = 5/group). Quantification of protein levels of UCP1 in sWAT, eWAT, and iBAT from adiponectin- or vehicle-treated ApoE/ mice exposed to 4C or 30C
(n = 5/group).
(F) Histological analysis and quantification of UCP1 positive signals of sWAT, eWAT, and iBAT from adiponectin- or vehicle-treated ApoE/mice exposed to 4C
or 30C (n = 5/group).
(G) Human plasma levels of LDL cholesterol and adiponectin after 2 days (2 hr/day) of cold exposure (n = 5). VT, vehicle-treated; Adipo, adiponectin-treated
group.
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Mechanisms of Cold-Promoted Atherosclerosisactivation-UCP1 axis is involved in cold-associated hyperlipid-
emia that contributes to cold-induced accelerated development
of atherosclerotic plaques. An independent line of lipolysis
evidence was provided using a known lipolysis inhibitor acipi-
mox, which inhibits atherosclerotic plaque development by
decreasing the circulating levels of LDL remnants. It appears
that increased lipolysis and cholesterol are two cohesively linked
processes because inhibition of cholesterol synthesis by simva-
statin results in a similar antiatherosclerotic effect. The detailed
molecular links by which lipolysis modulates cholesterol synthe-
sis warrant further mechanistic investigation.
Interestingly, circulating adiponectin levels were significantly
decreased in cold-exposed mice, and adiponectin has recently
been reported to suppress lipolysis (Qiao et al., 2011). Consis-
tent with our findings, activation of the sympathetic nervous sys-
tem by cold exposure has been reported to suppress circulating
levels of adiponectin (Imai et al., 2006). However, the functional
aspects of adiponectin in modulation of blood lipid profiles
have not been studied. In the present study, we describe our sur-
prising findings that systemic delivery of adiponectin protein to
cold-exposed ApoE/ mice could virtually completely prevent
atherosclerotic plaque growth and instability. In a genetic model,
crossbreeding between adiponectin/ mice with ApoE/ or
Ldlr/ mice did not produce an obvious phenotype of accel-
erated atherosclerotic plaque development (Nawrocki et al.,
2010). The key difference between this genetic model and our
cold-induced model is the activation of UCP1-dependent lipol-
ysis. Perhaps without activation of lipolysis as a driving force of
alteration of plasma lipid profiles, deletion of adiponectin alone
may be insufficient to study its role in accelerated plaque devel-
opment and instability. Although genetic deletion of adiponectin
may provide important clues to the molecular mechanisms of
adipokine-induced physiological changes, the relevance of this
genetic model to human patients who do not carry genetic dele-
tion of adiponectin is questionable.
Mechanistically, we showed that administration of adiponectin
markedly suppresses UCP1 expression at both mRNA and
protein levels, leading to ablation of cold-induced activation of
BAT and BRITE. Thus, adiponectin inhibits cold-induced
UCP1-dependent lipolysis, which essentially contributes to
atherosclerotic development in our mousemodels. Interestingly,
another study showed that induction of UCP1 expression in the
vessel wall also accelerated atherosclerotic plaque development
in major arteries of mice (Bernal-Mizrachi et al., 2005). This
previous study showed that local expression of UCP1 in the
vessel wall plays an important role in atherosclerotic plaque
development. In the present study, we show that cold-induced
adipose UCP1 expression is essential for atherosclerotic plaque
development. Nevertheless, this previous study and our present
findings point to the role of UCP1 in plaque development.
Perhaps upregulation of UCP1, independent of cell types and
location, could trigger expression of other factors that subse-
quently regulate the process of lipolysis. This possibility warrants
future investigation.
For healthy human individuals without preatherosclerotic
lesions, cold-induced BAT activity is probably beneficial for
health improvement. In supporting this hypothesis, cold expo-
sure of genetically nonmanipulated healthymice did not increase
plasma LDL cholesterol levels due to upregulation of Ldlr andApoE, both involved in high rates of cholesterol clearance. The
same is probably true for healthy humans. Patients with prea-
therosclerotic lesions may have to pay a ‘‘high price’’ for their
health when exposed to cold or living in a cold climate. In this
group of patients, protection from cold may significantly prevent
development of atherosclerosis-associated MI and stroke. The
similar lipolysis-mediated CVD mechanism may also apply to
other situations such as the drug-, chronic disease-, or even
physical exercise-induced lipolysis. Given the high incidence of
CVD as the leading cause of human mortality, a rigorous clinical
trial should be designed in the future to study the association of
the cold-induced BAT activity and development of CVD. Such a
clinical study will provide invaluable information for the develop-
ment of approaches for the prevention and treatment of CVD and
other metabolic disorders.EXPERIMENTAL PROCEDURES
Animal and Human Subjects
All animal and human studies complied with the Management Rules of the
Chinese Ministry of Health and were approved by the Ethical Committee of
Shandong University Qilu Hospital (See the Supplemental Information for
more information).
Generation of UCP1–/– and ApoE–/– Double Knockout Mice
For generation of UCP1/ and ApoE/ double knockout mice, UCP1/ and
ApoE/ were crossbred, and the double knockout strain was identified by
genotype using the tail DNA and a PCR-based method. The specific primers
for PCR reaction were provided by the commercial companies that supplied
these genetic mouse strains (Jackson Laboratory and the Pennington Bio-
medical Research Center).
Treatment with Simvastatin, Acipimox, b3-Adrenergic Antagonist
SR 59230A, or Adiponectin
Shortly before cold or thermoneutral temperature exposure, 8-week-old
ApoE/ mice (n = 15/group) were treated with or without simvastatin
(50 mg/kg/d, Tocris Bioscience), a lipolysis inhibitor acipimox (added into
drinking water; 0.05% w/w, Sigma-Aldrich), a selective b3-adrenergic antag-
onist SR 59230A hydrochloride (i.p. 5 mg/kg/day, Tocris Bioscience), or a
recombinant adiponectin (i.p. 1.5 mg/kg/day Prospec). At the end of the
4-week treatment, mice were sacrificed, and blood and tissue samples were
collected for various analyses.
Immunohistochemistry
Tissues prepared from cryosections or paraffin-embedded samples (5 mm
thickness) were immunohistologically stained with various primary antibodies,
including a nonimmune immunoglobulin G (IgG) (see above), followed by
further staining with secondary antibodies as previously described (Zhang
et al., 2010, 2011). For staining of blood vessels in the adipose tissue,
whole-mount technology was used, and positive signals were detected using
a confocal microscope (Zeiss 710). See the Supplemental Information for more
information.
Statistical Analysis
The data were shown as mean determinants ± SEM. Variables with skewed
distribution were analyzed by the Mann-Whitney test. For normal distribution
data, differences between two groups were assessed by unpaired Student’s
t test, and comparison of multiple groups involved the use of ANOVA.ACCESSION NUMBERS
The Gene Expression Omnibus (GEO) accession number for the data set
reported in this paper is GSE13432.Cell Metabolism 18, 118–129, July 2, 2013 ª2013 Elsevier Inc. 127
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Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
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